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Role of Somatostatin-Positive Cortical Interneurons in the
Generation of Sleep SlowWaves
XChaddM. Funk,1,2,3 Kayla Peelman,1 Michele Bellesi,1,4 XWilliamMarshall,1 XChiara Cirelli,1 and Giulio Tononi1
1Department of Psychiatry, 2Medical Scientist Training Program, and 3Neuroscience Training Program, University of Wisconsin–Madison, Madison,
Wisconsin 53705, and 4Department of Experimental and Clinical Medicine, Section of Neuroscience and Cell Biology, Universita` Politecnica delle Marche,
Ancona 60026, Italy
During non-rapid eye-movement (NREM) sleep, cortical and thalamic neurons oscillate every second or so between ON periods, charac-
terized by membrane depolarization and wake-like tonic firing, and OFF periods, characterized by membrane hyperpolarization and
neuronal silence. Cortical slow waves, the hallmark of NREM sleep, reflect near-synchronous OFF periods in cortical neurons. However,
themechanisms triggering such OFF periods are unclear, as there is little evidence for somatic inhibition.We studied cortical inhibitory
interneurons that express somatostatin (SOM), because70% of them are Martinotti cells that target diffusely layer I and can block
excitatory transmission presynaptically, at glutamatergic terminals, and postsynaptically, at apical dendrites, without inhibiting the
soma. In freely moving male mice, we show that SOM cells can fire immediately before slow waves and their optogenetic stimulation
during ON periods of NREM sleep triggers long OFF periods. Next, we show that chemogenetic activation of SOM cells increases
slow-wave activity (SWA), slope of individual slow waves, and NREM sleep duration; whereas their chemogenetic inhibition decreases
SWA and slow-wave incidence without changing time spent in NREM sleep. By contrast, activation of parvalbumin (PV) cells, the
most numerous population of cortical inhibitory neurons, greatly decreases SWAand cortical firing, triggers short OFFperiods inNREM
sleep, and increases NREM sleep duration. Thus SOM cells, but not PV cells, are involved in the generation of sleep slow waves.
WhetherMartinotti cells are solely responsible for this effect, or are complemented by other classes of inhibitory neurons, remains to be
investigated.
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Introduction
Non-rapid eye-movement (NREM) sleep is characterized by
spindles and slow waves. While the mechanisms responsible for
the generation of spindles are well characterized (Steriade, 2000),
those underlying slow waves remain unclear (Neske et al., 2015).
Slow waves are generated in the cerebral cortex even when iso-
lated from thalamic input (Steriade, 2000), although the thala-
mus is important for their full expression (Crunelli et al., 2015).
Every second or so during NREM sleep, when the EEG records
the occurrence of slow waves, cortical cells undergo a sharp hy-
perpolarization of the membrane potential lasting for tens to
hundreds of milliseconds (down state), during which neurons are
silent (OFF period). This is followed by a return to a tonic depo-
larization (up state) often accompanied by neuronal firing (ON
period). The near-synchronous occurrence of down states in
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Significance Statement
Cortical slowwaves are a defining feature of non-rapid eye-movement (NREM) sleep and are thought to be important formany of
its restorative benefits. Yet, themechanismbywhich cortical neurons abruptly and synchronously cease firing, the neuronal basis
of the slow wave, remains unknown. Using chemogenetic and optogenetic approaches, we provide the first evidence that links a
specific class of inhibitory interneurons—somatostatin-positive cells—to the generation of slow waves during NREM sleep in
freely moving mice.
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large sectors of the cortex is detected in the EEG as the negative
peak that typifies each slow wave. It was suggested that the OFF
periods that characterize NREM sleep may occur, upon a back-
ground of increased potassium leak currents, through a passive
“disfacilitation” associated with reduced synaptic input (Ste-
riade, 2000). However, it is not clear what would trigger a de-
crease in synaptic input in the first place. Moreover, it is difficult
to explain why the occurrence of OFF periods is remarkably sharp
and synchronous across large populations of neurons (Volgushev
et al., 2006). Finally, if reduced activity were the primary trigger of
slow waves, it would be hard to explain why they can be induced
reliably by electrical (Vyazovskiy et al., 2009a) or transcranial
magnetic stimulation (Massimini et al., 2007). An alternative
possibility is that down states may be induced by active inhibition
(Craig et al., 2013; Lemieux et al., 2015). However, except for a
small fraction of pyramidal neurons (Lemieux et al., 2015),
intracellular recordings in the cell body of pyramidal cells are
consistent with disfacilitation rather than with direct inhibition
(Steriade, 2000), and there is currently no causal evidence for the
involvement of specific inhibitory cell types in the generation of
slow waves.
We reasoned that a prominent class of cortical inhibitory
interneurons that express somatostatin (SOM)—Martinotti cells—
have several features that could explain the synchronous induc-
tion of OFF periods and associated slow waves in the absence of
somatic inhibition. First, Martinotti cells are found throughout
the cortex and their defining anatomical feature is an extensive
network of ascending axonal collaterals that especially target
layer 1 (L1; Wang et al., 2004), the site of termination of many
corticocortical connections, particularly back connections, and
of diffusely projecting thalamocortical projections from matrix
cells (Cauller, 1995; Markov et al., 2014). In L1, SOM cells
powerfully inhibit excitatory transmission among pyramidal cells
(Urban-Ciecko et al., 2015) through synaptic spillover over pre-
synaptic GABAB receptors on glutamatergic terminals, which
could explain the profound disfacilitation at the cell body despite
little evidence for inhibitory currents (Steriade, 2000). Moreover,
in L1, SOM cells inhibit distal dendrites of pyramidal cells (Sil-
berberg and Markram, 2007) through GABAA (Chiu et al., 2013)
and likely GABAB receptors (Wang et al., 2010; Craig and
McBain, 2014). Martinotti cells have high density of connections
and convergence onto pyramidal cells, regardless of specific
subnetworks, and can thus provide indiscriminate pyramidal in-
hibition (Fino and Yuste, 2011; Lee and Huguenard, 2011). Fur-
thermore, SOM cells are activated by strong synchronous firing
of pyramidal cells (Kapfer et al., 2007; Fanselow et al., 2008)
through progressively facilitating synapses (Silberberg and
Markram, 2007; Fanselow and Connors, 2010). When many
SOM cells are activated together, they act as “master regula-
tors,” inhibiting all other cell types but themselves (Jiang et al.,
2015), in line with the observations that OFF periods are found
across cell types (Steriade, 2000). SOM cells tend to fire more
strongly late during the up state, and have been implicated in the
termination of the up state in computer simulations (Krishna-
murthy et al., 2012) and in vitro (Fanselow and Connors, 2010),
possibly by activating GABAB receptors (Wang et al., 2004; Craig
and McBain, 2014). Finally, Martinotti cells have uniquely broad
and complex axonal arborizations (Wang et al., 2004), which
could account for the broad synchrony of sleep slow waves (Ste-
riade, 2000), and they form an electrical syncytium through gap
junctions (Ma et al., 2006; Fanselow et al., 2008), which could
favor the spread of slow waves in the cortex and possibly account
for their traveling nature (Massimini et al., 2004). Consistent
with this hypothesis, we establish here an important role for
SOM cells in the generation of sleep slow waves.
Materials andMethods
Animals
Adult (9 weeks old; body weight, 23–32 g) male mice, all from Jackson
Laboratory, were used, including transgenic lines SOM-Cre [B6N.Cg-
Ssttm2.1(cre)Zjh/J (Stock #018973, RRID:IMSR_JAX:018973)] and
parvalbumin (PV)-Cre (B6;129P2-Pvalbtm1(cre)Arbr/J (#008069, RRID:
IMSR_JAX:008069) and B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)
Hze/J (#007914, RRID:IMSR_JAX:007914)], and C57BL/6 wild-type
mice. All animal surgical procedures were performed according to the
National Institutes of Health Guide for the Care and Use of Laboratory
Animals. Facilities were reviewed and approved by the Institutional An-
imal Care and Use Committee of the University of Wisconsin–Madison,
and were inspected and accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care. Sample size was based on past
experience and pilot experiments.
Virus injection
Under isoflurane anesthesia (2% induction; 1–1.5% maintenance)
SOM-Cre or PV-Cre mice were fitted to a stereotactic frame. Using sterile
technique, a midline incision was made to expose the skull. After cleaning
with saline and hydrogen peroxide, a small burr hole was made in the
skull using a dental drill. Either one or four craniotomies were per-
formed, depending on the injection strategy. For tracing experiments,
AAV1.CAG.Flex.eGFP.WPRE.bGH (1.79 10 13 GC/ml) was injected in
frontal cortex (n  3 SOM-Cre; n  3 PV-Cre; 1.60 mm anterior to
bregma,0.70 mm lateral to midline) using iontophoresis (Harris et al.,
2012). For all other injections, a cannula-based approach was used, at a
rate of 0.15 l/min, with a total of 2 l delivered. For chemogenetic
experiments, frontal (1.60 mm anterior to bregma,0.70 mm lateral to
midline) and parietal (2.1 mm from bregma,1.5 mm from midline)
regions were bilaterally injected with 2 l of AAV8-hSyn-DIO-hM3D(Gq)-
mCherry, or with AAV8-hSyn-DIO-hM4D(Gi)-mCherry (University of
North Carolina, UNC Vector Core, RRID:SCR_002448; based on previ-
ous work by Dr. Bryan Roth). For optogenetic experiments, mice were
injected with C1V1 [AAV5-EF1a-DIO-C1V1(E122T/E162T)-TS-EYFP;
UNC Vector Core; under an agreement with Dr. Karl Deisseroth] in one
frontal site. Five minutes after the injection, the cannula was removed,
and a custom-fashioned dental cement flap was secured above the crani-
otomy to protect the cortex. Then mice were sutured and anesthesia was
terminated. Mice were monitored daily for 7 d following surgery to en-
sure normal recovery. We estimated the extent of the virus expression
and the colocalization with SOM expression in six animals, four for M3
and two for M4, and we got consistent results: 69 –70% of infected cells
express SOM, and almost all SOM cells (94 –95%) express either the
M3 or the M4 virus. In a subset of mice, coronal sections spanning the
frontal (from 1.94 to 1.18 mm anteroposterior) and parietal (from
1.34 to 2.20 mm anteroposterior) regions were taken from seven
mice and the cells expressing either hM3Dq (four mice) or hM4Dq
(three mice) and SOM ( polyclonal rabbit anti-somatostatin; 1:250; Santa
Cruz Biotechnology, RRID:AB_2195930) were counted. In each section,
512 512 pixel images were acquired in the left and right cortices with a
confocal microscope (Olympus BX61W1; 40) using the red and green
channels. mCherry cells and SOM cells were counted independently
in each channel and then compared to assess the degree of colabeling. On
average 70% of hM3Dq or hM4Dq cells were also SOM (61 to
80% in different mice) and almost all (94 –95%) SOM cells also ex-
pressed hM3Dq or hM4Dq.
Electrode implant
At least 2 weeks after adeno-associated virus (AAV) injection, mice were
anesthetized with isoflurane (2% induction; 1–1.5% maintenance) and
implanted with electrodes to assess brain and muscular activity. The EEG
was recorded by fixing gold screws in burr holes (0.7 mm) above the
frontal and/or parietal cortex, with a screw above the cerebellum serving
as reference (Fig. 1B). Anchor screws were also placed above the cerebel-
lum and olfactory bulbs. Craniotomies were performed at target cortical
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areas, ensuring that the dura remained intact, followed by insertion of
laminar silicon probes (NeuroNexus, A1x16; 50 or 100 m site spacing)
perpendicular to the target cortical regions. In areas previously injected
with AAV, probes were placed slightly caudal to the injection site (but
still well within the viral expression area) to avoid recording near the
injection cannula track. The dorsoventral dimension was adjusted dur-
ing surgery to ensure that the top contact was placed at the surface of the
cortex (100 m spaced probes) or just below the brain surface (50 m
spaced probes). In mice injected with C1V1, a custom-fabricated optrode
consisting of a fiber optic ferrule (Doric Lenses) cemented to a Neu-
roNexus A1x16 probe was implanted in the secondary motor cortex
(M2) such that the optic ferrule rested on the surface of the cortex. A
second NeuroNexus probe was inserted nearby. To help us verify probe
location using histological techniques later on, the back of each was
covered with a thin layer of DiI fluorescent dye [DiIC18(3), Invitrogen].
Two-component silicon (QuikSil) was applied to craniotomy and probe,
followed by dental acrylic (Fusio) to secure the array. To record muscle
activity, a pair of custom-made electromyogram (EMG) cables was in-
serted bilaterally into the dorsal neck musculature and in the vibrissal
musculature.
Chronic sleep recordings and sleep deprivation
Single implanted mice were housed in transparent Plexiglas cages
(36.5 25 46 cm) for the duration of the experiment (12 h light/dark
cycle; light on at 8:00 A.M.; 23 1°C; food and water available ad libitum
and replaced daily at 8:00 A.M.). After1 week of recovery from surgery,
chronic 24 h recordings started at the beginning of the light phase. Data
acquisition was performed with the Multichannel Neurophysiology
Recording and Stimulation System (Tucker-Davis Technologies,
RRID:SCR_006495), with spike data being accumulated continuously
across the 24 h cycle. local field potentials (LFPs; 256 Hz, 0.1–100 Hz),
multiunit activity (MUA; 25 kHz, 300–5000 Hz), surface EEGs (256 Hz,
0.1–100 Hz), and EMGs (256, 10–100 Hz) were acquired using a PZ amplifier
and RZ2 system (Tucker-Davis Technologies, RRID:SCR_006495). Voltage
thresholds were determined by visual inspection. Both time stamps and
waveforms (46 perithreshold crossing samples) were attained for each
suprathreshold event. Sleep deprivation was performed using novel ob-
jects and bedding changes during the first 6 h of the light phase. Since the
procedure can be stressful in naive animals, mice were familiarized with
the method by placing a new object in the cage every day for several days
before the sleep deprivation experiment. During sleep deprivation, mice
were given a new object or bedding every time they were inactive and
slow waves became evident on real-time EEG monitoring. Mice were
never disturbed when they were spontaneously awake, feeding, or
drinking.
Chemogenetic and optogenetic experiments
For chemogenetic activation experiments, mice were injected with
clozapine-N-oxide (CNO; 5 mg/kg, i.p.) either at the start of the dark
phase (8:00 P.M.) or 6 h after light onset (2:00 P.M.). All mice that
received CNO during the day were also subjected to 6 h of sleep depriva-
tion, to directly compare the effects of sleep loss with those of CNO
stimulation. Baseline, sleep deprivation, and the CNO experiment oc-
curred in the same order and in 3 consecutive days to increase the chance
of recording from the same units. Sleep deprivation always preceded the
CNO experiment because in our experience the recovery from 6 h of
Figure 1. Projections of cortical SOM cells and experimental design. A, Long-range cortical projections shown in sagittal and coronal sections from a representative SOM-Cre mouse injected
with AAV1.CAG.Flex.eGFP.WPRE.bGH. Dense innervation in L1 is shown at higher magnification (bottom right). D, Dorsal; V, ventral; A, anterior; P, posterior; M, medial; L, lateral. B, Placement of
the electrodes, schematic of the injection sites, and timeline. Red and green dots on the skull mark the injection site of the AAV constructs, which contained the fluorescent protein mCherry (red,
chemogenetics) or EYFP (green, optogenetics); yellowscrewsandbluedots indicate thepositionof theEEGelectrodesandLFPprobes (M2), respectively. Continuous recordings lasted for several days
and included baseline, sleep deprivation with novel objects (gray bar), and opto/chemogenetics experiments at different times of the light/dark cycle.
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sleep loss is completed within the first 24 h cycle, while we could not rule
out residual effect of CNO the next day. Indeed, when we compared the
first 5 h of the light period during baseline with the first 5 h of the day
following sleep deprivation—that is, before CNO was administered—we
found no difference in percentage of wake, NREM sleep, and REM sleep,
number and duration of wake and sleep bouts, and slow-wave activity
(SWA) during NREM sleep. For chemogenetic inhibition experiments,
mice were injected with CNO (10 mg/kg, i.p.) at the start of the light
phase (8:00 A.M.), when sleep pressure and SWA reach the highest levels
(Borbe´ly et al., 2016). A high concentration of CNO (10 mg/kg) was used,
in line with previous studies that used hM4Di to decrease neuronal ac-
tivity (Wess et al., 2013), and specifically to inhibit SOM cells (Li et al.,
2013; Hamm and Yuste, 2016). To control for possible sedative effects of
CNO alone, due to back metabolism to clozapine (Urban and Roth,
2015), mice injected in M2 with a non-hM3Dq AAV (DIO-C1V1 or
DIO-mCherry) were given CNO at the same dose (5 mg/kg, i.p.) and
time of day (6 h after light onset) as the SOM-Cre hM3Dq mice, and
mice injected in M2 with a non-hM4Di AAV (DIO-C1V1) were given
CNO at the same dose (10 mg/kg, i.p.) and time of day (light onset) as the
SOM-Cre hM4Di mice. For optogenetic experiments, yellow light
pulses (594 nm, 10 mW, 20 or 50 ms on, 2980 or 2950 ms off) were
delivered in M22 h after the start of the light phase, to avoid the period
of the day with the highest sleep pressure. For tagging experiments, pulses
(20 ms) were delivered at the start or at the end of the light phase.
Experimenters were not blinded to mouse genotype or experimental
condition.
Sleep scoring
Signals were loaded with a custom Matlab script and subsequently pro-
cessed into European Data Format (EDF). EEG, LFP, and EMG activity
were analyzed off-line by visual inspection of 4 s epochs using a graphic
interface (SleepSign, Kissei Comtec), where all signals are displayed si-
multaneously to determine behavioral state. Sleep/wake scoring was
done according to standard criteria and vigilance state could always be
determined. Wake was characterized by low-amplitude, high-frequency
EEG/LFP activity and high EMG content. NREM sleep was characterized
by high-amplitude, low-frequency EEG/LFP activity and low EMG activ-
ity. In REM sleep EEG/LFP activity was similar to that of wake, but
accompanied by strong  (6 –9 Hz) in EEG/LFP channels and occasional
high whisker EMG activity. For some analyses, wake epochs were further
divided into active and quiet wake based on EMG content. We looked at
EMG activity in the top 33rd percentile (active wake) or bottom 33rd
percentile (quiet wake) of all wake EMG activity for the entire 24 h
baseline.
Electrophysiological data analysis, slow-wave analysis, and
spike sorting
Most analyses were performed using custom Matlab scripts. For experi-
ments in which CNO was given at 2:00 P.M., the first sleep episode after
2:00 P.M. was identified and each 1 h bin was locked to this time point.
The 1 h bins between “lights on” and 2:00 P.M. were locked to the first
sleep episode at the start of the light period. All statistical analyses were
performed using data in 1 h bins, including percentage time spent in
sleep or wake, number, and duration of sleep and wake bouts. When the
linear mixed effect (LME) models found a significant condition (group)
by day interaction, post hoc tests were run to isolate the main effect of
CNO (averaged across all hours; 7–11 for 2:00 P.M. experiments; 1– 6 for
8:00 A.M. experiments), as detailed below (see description of LME mod-
els). In some cases, the CNO models identified other significant effects
(e.g., a main effect of time, or an time by day interaction), which are not
reported here because it is outside the main focus of the study. Spectral
analysis was performed using a fast Fourier transform in 4 s epochs using
FieldTrip scripts (Oostenveld et al., 2011). For all LFP spectrograms,
LFPs from layer 5 were used. EEG signals contaminated by constant
artifact were excluded. For analysis of spectral activity within a specific
frequency band, including SWA, all data were normalized to the mean
power in that band for each behavioral state during the entire baseline
light period (12 h). Only consolidated bouts of wake (1 min), NREM
sleep (1 min), and REM sleep (40s) were used for this analysis to
avoid transitional or ambiguous states.
For analysis of individual slow-wave parameters and MUA locked to
slow waves, the LFP was bandpass filtered from 0.5 to 4 Hz and slow
waves were defined as positive peaks between two zero crossings, as in
previous studies (Vyazovskiy et al., 2007, 2009b). Only consolidated
NREM-sleep episodes (1 min) were used. In all analyses, the slow-wave
amplitude for the 75 th percentile of all slow waves detected during the
baseline light phase was used as a cutoff for that recording and subse-
quent sleep deprivation or chemogenetic activation/inactivation blocks.
MUA was locked to the zero crossing for each slow wave, since this closely
approximates the onset of the OFF period.
For analysis of MUA locked to slow waves, MUA from 1 to 1 s,
relative to the slow-wave zero crossing, was isolated. Firing rate for this
period was normalized to the baseline firing rate, defined as1 to0.5
s before the peak of the slow wave. For optogenetic experiments, pulses
delivered during each behavioral state were identified and analyzed sep-
arately. For each pulse, MUA from 1 to 1 s after the pulse was ob-
tained on each channel. MUA activity was normalized to prepulse firing
(1 to 0 s) and averaged across channels for the M2 probe. MUAs from
all channels on the M2 probe were concatenated into a single spike train,
and OFF periods were defined as 100 ms of silence following the start of
the pulse. For the OFF-period analysis during NREM sleep, only pulses
given during an ON period (defined by the presence of firing at the onset
of the pulse) were used. To calculate the latency of the first spike follow-
ing the pulse, the median latency was calculated and averaged across
mice.
For analysis of sleep spindles after chemogenetic stimulation, two
analyses were performed. First, LFP spectral power in the spindle range
was calculated as described above. Second, individual spindles were de-
tected off-line using previously published methods (Nir et al., 2011). The
LFP from layer 5 was filtered from 10 to 16 Hz and the instantaneous
amplitude was calculated using the Hilbert transform. A detection
threshold of 3 SD (based on baseline light period) was used to identify
local maxima, and a second threshold of 1 SD was used to define the
beginning and end of each event. Events occurring within a second of
each other were merged, and only events lasting from 0.5 to 2 s were
considered.
To test whether SOM-cell optogenetic stimulation induced spindles,
spindle events were automatically detected in the 2 s after the pulse start,
using cutoff thresholds for 10 –16 Hz instantaneous amplitude based on
NREM sleep without pulses. Across all animals, only 0.9 0.3% of pulses
were followed by a spindle, indicating that the stimulation did not effec-
tively trigger spindles in subsequent ON periods. Laser stimulation also
had little, if any, effects on sleep based on statistical analysis of episode
length and percentage time in each state using t tests. Specifically, no
significant change in the duration of NREM-sleep episodes (laser off:
39 8 s; on: 42 11 s, t(6)1.2, p 0.26, paired t test) or REM-sleep
episodes (off: 56 6 s; on: 56 11 s, t(6) 0.13, p 0.90, paired t test)
and a small decrease in wake episode length (off: 40 7 s; on: 28 8 s,
t(6)  5.8, p  0.001, paired t test) occurred when the laser was on
compared with when it was off. In fact, during laser stimulation, mice
actually spent more time in NREM sleep (off: 45  4%; on: 55  5%,
t(6)4.6, p 0.004, paired t test) and less time in wake (off: 47 5%;
on: 37 5%, t(6)  4.6, p 0.004, paired t test).
To analyze the effect of optogenetic stimulation on single units and for
optogenetic tagging experiments, spike sorting was performed off-line
using supraparamagnetic clustering (Quiroga et al., 2004). Visual inspec-
tion of clustered waveforms was carried out both to discriminate between
single-unit (SU) activity and MUA, and to determine consistency in
waveform shape. Unit stability was assessed by plotting both the firing
rate in 4 s epochs and the waveform maximum amplitude. Clusters were
only considered to be single units if	3% of all interspike intervals (ISIs)
were 	3 ms (which represent refractory violations). Other metrics in-
spected include an estimate of false negatives due to spikes missed based
on the channel threshold and the distribution of waveform minima, and
Fisher’s linear discriminant, which identifies potential overlap of wave-
form characteristics between a pair of clusters on the same channel (Hill
et al., 2011). Units with spike width at half maximum amplitude 	0.25
ms were categorized as narrow, putative inhibitory neurons, and those
0.25 ms were categorized as broad, putative excitatory neurons.
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To examine the effects of optogenetic SOM-cell activation on SU
firing, spikes for each unit 1 s before/after each pulse delivered in NREM
sleep were detected. Firing was normalized to baseline firing from1000
to 500 ms relative to the pulse. To examine firing of putative SOM
units, 30 min of consolidated active wake, quiet wake, NREM sleep,
and REM sleep were used. Firing rates were calculated for 4 s epochs. The
correlation between firing rate and either SWA or 10 –16 Hz (spindle
power range) from a layer-5 LFP across all 4 s NREM-sleep epochs were
calculated using the Matlab “corr” function. LFP slow waves were de-
tected, and firing from1 to1 s after the zero crossing was calculated
for each unit. To assess slow wave-locked firing, simulated spike trains
from the same NREM episodes were generated using ISI shuffling to
preserve both firing level and temporal structure. For each NREM epi-
sode, this simulation was repeated 1000 times, and a threshold for firing
rate at each time point was set based on the 99th percentile. Firing rates
above this threshold were taken as evidence of slow-wave-locked firing.
In two mice with a putative SOM unit, sleep deprivation recordings were
also performed following the baseline recording. For each unit, spikes
from early NREM (first 3 h of baseline), late NREM (last 3 h of baseline),
and recovery sleep (from first 3 h following sleep deprivation) were com-
bined and sorted together. Waveforms from each condition were in-
spected separately to ensure unit stability. Firing locked to slow waves
was calculated as described above.
Tracing and CNO-mediated Fos activation experiments
For SOM and PV tracing experiments, animals were given 26 d to express
the virus before being killed. Mice were then anesthetized with isoflurane
(3% volume) and perfused transcardially with a flush (30 s) of saline
followed by 4% paraformaldehyde in phosphate buffer (PB), pH 7.4.
Brains were removed, postfixed for 24 h in the same fixative, cut on a
Vibratome in 50 m sagittal and coronal sections, and collected in PB.
Sections were then mounted, air-dried, and examined under a confocal
microscope using a Lump Plan Fl 20 objective (numerical aperture,
0.95). Image analysis was performed in FIJI and Adobe Photoshop.
For Fos activation experiments, mice expressing hM3Dq received
CNO 2 h before perfusion to detect CNO-driven Fos expression. Mice
were anesthetized with isoflurane (3% volume) and perfused as de-
scribed above. Brains were cut on a Vibratome in 50 m coronal sec-
tions that were then rinsed with a 1% H2O2 solution followed by a
blocking solution [3% NGS (MP Biomedicals, catalog #08642921, RRID:
AB_2335031) and 0.1% Triton X-100] for 2 h, and incubated overnight
in the blocking solution containing rabbit anti-Fos antibody (1:4000;
Santa Cruz Biotechnology, sc-52, RRID:AB_2106783). A Tyramide
Signal Amplification kit (TSA, T20922, Life Technologies) was used to
amplify the Fos signal. Sections were then mounted, coverslipped, and ex-
amined under a confocal microscope using a UPlan FL N 40 objective
(numerical aperture, 1.3).
Colocalization experiments
Two pilot studies [Fos/neuronal nitric oxide synthase (nNOS) and SOM/
nNOS] were conducted to confirm previously published findings. For
the Fos/nNOS experiment, two C57BL/6 wild-type mice were kept awake
for 6 h from light onset using novel objects, then allowed to sleep for90
min (Gerashchenko et al., 2008), and then perfused. The duration of
recovery sleep was selected based on previous studies that identified cor-
tical Fos/nNOS cells during early recovery sleep (Kilduff et al., 2011).
Brains were cut and coronal sections (two frontal, two parietal, two oc-
cipital per mouse) were rinsed with a 1% H2O2 solution followed by a
blocking solution (3% NGS and 0.1% Triton X-100) for 2 h, and incubated
overnight in the blocking solution containing a mixture of antibodies (rabbit
anti-Fos, 1:4000, RRID:AB_2106783, and mouse anti-nNOS, 1:5000,
Sigma-Aldrich, N2280, RRID:AB_260754). The next day, sections were
washed and reacted with secondary antibody (Alexa Fluor 568, 1:1000;
Invitrogen, RRID:AB_10563566) for nNOS, while a TSA (T20922, Life
Technologies) was used to amplify the Fos signal. Sections were exam-
ined under a confocal microscope using a UPlan FL N 40 objective
(numerical aperture, 1.3). Microscopic fields were selected as 512 512
pixel images. The entire cortex within each section was visually scanned
and the number of SOMnNOS cells was counted. In the second pilot
experiment (SOM/nNOS), four SOM reporter mice [B6N.Cg-
Ssttm2.1(cre)Zjh/J  B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)
Hze/J] were kept awake for 6 h from light onset using novel objects. Two
mice were immediately perfused (sleep deprivation), while the remain-
ing two mice were allowed to sleep for 90 min (recovery sleep) and then
perfused. Coronal sections (one frontal, one parietal per mouse) were
rinsed with a blocking solution (10% NGS) for 1 h, and incubated over-
night with mouse anti-nNOS (1:5000; Sigma-Aldrich, N2280, RRID:
AB_260754). The next day, sections were washed and then rinsed with
secondary antibody (Alexa Fluor 488, 1:1000; Invitrogen). Sections were
examined under a confocal microscope using a UPlan FL N 40 objec-
tive (numerical aperture, 1.3). Microscopic fields were selected as 512
512 pixel images. The entire cortex within each section was visually
scanned and the number of SOMnNOS cells was counted. Consis-
tent with published work (Kubota et al., 1994), in all four mice most
(95% 0.04, mean SD) of nNOS cells were also SOM, while only
a minority (11% 0.02) of SOM cells were also nNOS.
For Fos/SOM experiments, the brains of six SOM reporter mice (two
sleep deprivation; four recovery sleep) were cut and coronal sections
(two frontal, two parietal, two occipital per mouse) were rinsed with a 1%
H2O2 solution followed by a blocking solution (3% NGS and 0.1% Tri-
ton X-100) for 2 h, and incubated overnight in the blocking solution
containing rabbit anti-Fos antibody, followed by TSA to amplify the Fos
signal. Sections were examined under a confocal microscope using a
UPlan FL N 40 objective (numerical aperture, 1.3). Microscopic fields
were selected as 512  512 pixel images of superficial (I–III, five fields)
and deep (IV–VI, five fields) layers.
Experimental design and statistical analysis using LME models
For the chemogenetic experiments, statistical analysis was performed
using LME models (Laird and Ware, 1982). The use of LME models
offers several advantages over traditional ANOVA methods for repeated
measures, including the ability to handle unbalanced designs and greater
flexibility for post hoc tests. The general matrix form of the LME is as
follows: y X Zu , where u N(0, 
) and  N(0, I 2).
In these models, y is the response variable (e.g., SWA), u are the ran-
dom effects for each individual mouse (assumed to be independent and
normally distributed, with mean zero and covariance matrix
), are the
fixed effects, and X and Z are design matrices that link the particular
responses to  and u. The residuals  are assumed to be independent and
normally distributed with constant variance .
The set of random and fixed effects included in each model was deter-
mined using the Akaike Information Criterion (AIC). For the random
effects, we looked for the minimum AIC value, but if several models had
similar AIC values, we took the one that included the most random
effects, as omitting random effects can introduce errors when testing the
significance of fixed effects. Conversely, the fixed effects were selected by
identifying the specific model that minimizes the AIC. Parameter estima-
tion of LMEs was performed using numerical maximum-likelihood es-
timators, implemented in R by the lmer() function of the lme4 package
(Bates et al., 2015). To test the significance of effects in the LME model,
we used likelihood ratio tests. Under the hypothesis that the experiment
(e.g., CNO injection) had an effect on SWA, we expected that there
should be no differences between conditions (groups; e.g., hM3Dq vs
non-hM3Dq mice) during the baseline day, but significant differences
between groups on the CNO day. Thus, we specifically tested for a
condition*day interaction effect; if the interaction was found to be sig-
nificant, we then performed post hoc tests to confirm that there was in fact
no difference in the baseline day and a significant difference in the CNO
day. Additional LME models were also fit to test the effects of sleep
deprivation. These models did not include condition as a fixed effect as
there was no corresponding control group for the sleep deprivation con-
dition. All post hoc comparisons in the LME models were z tests, per-
formed using the glht() function of the multcomp package in R, with p
values adjusted for multiple comparisons using the single-step method
(Bretz et al., 2011). For all models, residual plots were used to assess the
normality and constant variance assumption of the LME, and in some
cases a log transformation was applied if necessary to satisfy these as-
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sumptions. Below we give the full details for the three main experimental
results; however, all statistical analyses were performed using the same
process, albeit with potentially different model structures.
LME models
Chemogenetic activation of SOM cells.The AIC analysis selected a model
for SWA that included Condition (hM3Dq vs non-hM3Dq, n 6 male
mice/group), Day (baseline vs CNO day), and Hour, as well as a
Condition*Day interaction and an Hour*Day interaction. A log trans-
formation was applied to the response variable to satisfy the modeling
assumptions. Parameter estimates for the LME model of SWA are shown
in Table 1. Residual plots were used to assess the model assumptions of
normality and constant variance. From the scatter plot of residuals versus
fitted values, we found no evidence against either of the assumptions. The
LRT revealed a significant Condition*Day interaction (	 2 14.69, df
1, p 0.0001), and subsequent post hoc tests found no significant differ-
ences between groups during the baseline day (z  0.785, p  0.607,
2.78% decrease) and a significant increase in SWA for the hM3Dq mice
compared with the control group (non-hM3Dq mice) during the CNO
day (z 4.371, p 2.4e-5, 49.74% increase).
Chemogenetic inhibition of SOM cells. The AIC analysis selected a
model for SWA that included Condition (hM4Di vs non-hM4Di, n 5
male mice/group), Day, and Hour, as well as a Condition*Day interac-
tion and an Hour*Day interaction. A log transformation was applied to
the response variable to satisfy the modeling assumptions. Parameter
estimates for the LME model of SWA are shown in Table 2. Residual plots
were used to assess the model assumptions of normality and constant
variance. From the scatter plot of residuals versus fitted values, we found
no evidence against either of the assumptions. The LRT revealed a signif-
icant Condition*Day interaction (	 2  15.56, df  1, p  8.0e-5), and
subsequent post hoc tests found no significant differences between groups
during the baseline day (z  0.068, p  0.996, 0.21% decrease) and a
significant decrease in SWA for the hM4Di group compared with the
control (non-hM4Di) group during the CNO day (z  4.612, p 
7.8e-6, 18.56% decrease).
Chemogenetic activation of PV cells. The AIC analysis selected a
model for SWA that included Condition (hM3Dq vs non-hM3Dq; n 5
and 3 male mice, respectively), Day, and Hour, as well as a Condition*Day
interaction and a Condition*Hour interaction. A log transformation was
applied to the response variable to satisfy the model assumptions of
normality and constant variance. Parameter estimates for the LME
model of SWA are shown in Table 3. Residual plots were used to assess
the model assumptions of normality and constant variance. From the
scatter plot of residuals versus fitted values, we found no evidence against
either of the assumptions. The LRT revealed a significant Condition*Day
interaction (	 2  12.839, df  1, p 0.0003), and subsequent post hoc
tests found no significant differences between groups during the baseline
day (z 1.152, p 0.424, 4.08% increase) and a significant decrease in
SWA for the hM3Dq group compared with the non-hM3Dq control
group during the CNO day (z4.817, p 2.9e-6, 54.27% decrease).
Results
Characterization of SOM activity in natural sleep
There is currently no molecular marker to target Martinotti cells
exclusively (Urban-Ciecko and Barth, 2016). Instead, we used
SOM-Cre mice (Taniguchi et al., 2011), because Martinotti cells
form the bulk (70%) of SOM-expressing cells in the cortex
(Jiang et al., 2015). AAV-driven expression of Cre-dependent
enhanced green fluorescent protein in SOM-Cre mice confirmed
that SOM cells have strong projections to L1 both locally and
up to several millimeters away from the injection site (Fig. 1A),
consistent with the known projections of Martinotti interneu-
rons (Wang et al., 2004). We then injected SOM-Cre mice either
in one frontal site (M2) with Cre-inducible AAV expressing
channelrhodopsin-2 (ChR2), or bilaterally in the frontal (M2)
and parietal cortex with Cre-inducible AAV expressing the de-
signer receptors hM3Dq or hM4Di. After 3 weeks to allow for
viral expression, mice were implanted with frontal and parietal
EEG electrodes and intracortical laminar probes in M2, and con-
tinuously recorded for several days across multiple sleep–wake
Table 1. LME, chemogenetic activation of SOM cells log(SWA) during NREM
Estimate SE
Random effects
Mouse
Intercept 0.0394
Day–CNO (correlation with intercept: 1.0) 0.0935
Residual 0.0808
Fixed effects
Intercept 0.0826 0.0340
Condition (group)
Control (non-hM3Dq, reference) 0 0
hM3Dq 0.0282 0.0359
Day
Baseline (reference) 0 0
CNO 0.2348 0.0586
Hour
7 (reference) 0 0
8 0.0267 0.0381
9 0.0119 0.0381
10 0.0902 0.0381
11 0.0852 0.0381
Condition*Day interaction
Control, baseline (reference) 0 0
hM3Dq, CNO 0.4319 0.0715
Hour*Day interaction
7, baseline (reference) 0 0
8, CNO 0.1999 0.0539
9, CNO 0.2800 0.0539
10, CNO 0.2497 0.0539
11, CNO 0.2380 0.0539
Table 2. LME, chemogenetic inhibition of SOM cells log(SWA) during NREM
Estimate SE
Random effects
Mouse
Intercept 0.0386
Day–CNO (correlation with intercept: 0.71) 0.0292
Residual 0.0780
Fixed effects
Intercept 0.2923 0.0317
Condition (group)
Control (non-hM4Di, reference) 0 0
hM4Di 0.0021 0.0316
Day
Baseline (reference) 0 0
CNO 0.1783 0.0399
Hour
1 (reference) 0 0
2 0.1936 0.0349
3 0.2481 0.0349
4 0.3065 0.0349
5 0.3465 0.0349
6 0.4041 0.0349
Condition*Day interaction
Control, baseline (reference) 0 0
hM4Di, CNO 0.2075 0.0339
Hour*Day interaction
1, baseline (reference) 0 0
2, CNO 0.1028 0.0493
3, CNO 0.1760 0.0493
4, CNO 0.1588 0.0493
5, CNO 0.1000 0.0493
6, CNO 0.0998 0.0493
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cycles, during sleep deprivation and subsequent recovery sleep, as
well as during and after optogenetic or chemogenetic stimulation
(Fig. 1B).
First, we characterized the firing pattern of 3 SOM cells in
M2 that were identified by optogenetic tagging in freely moving
animals (Fig. 2A) and whose activity could be followed for several
days during the sleep–wake cycle (Fig. 2B). All three cells exhib-
ited state-specific firing modulation, with higher firing levels dur-
ing active wake with exploration relative to quiet wake (Pinto and
Dan, 2015; but see Gentet et al., 2012) and during NREM sleep
relative to REM sleep (Fig. 2C). Two of these cells were also recorded
during recovery sleep after sleep deprivation, when they fired
more than during baseline sleep (Fig. 2D). In these cells, firing
was positively correlated with SWA, both in baseline and after
sleep deprivation (Fig. 2E). In all three cells, firing significantly
increased between 50 and 100 ms before the onset of locally de-
tected slow waves, consistent with a link between SOM-cell
firing and SWA in natural sleep (Fig. 2F). Although correlative
and restricted to a few neurons, these results are consistent with
the hypothesis that SOM-cell firing may be linked to the occur-
rence of slow waves in natural sleep. By contrast, SOM-cell
firing was negatively correlated with spindle activity (Fig. 3).
Optogenetic SOM activation induces OFF periods
To directly test whether SOM-cell firing is sufficient to induce
OFF periods in the local cortical network of freely moving ani-
mals, we used optogenetic stimulation to briefly activate SOM
cells in M2 during the ON periods of NREM sleep, while record-
ing MUA and SU activity from the same area. SOM-cell activa-
tion with laser pulses (50 ms) consistently induced OFF periods
in MUA that outlasted the duration of the pulse and were com-
parable in length to those occurring during stimulation-free
NREM sleep (190  32 ms vs 174  10 ms; mean  SD).
Stimulation-induced OFF periods occurred in all recorded M2
channels, including a majority whose MUA decreased during the
pulse and remained decreased in the subsequent OFF period, and
a few channels whose MUA sharply increased during the pulse.
These “responding” channels, which presumably contained 1
SOM cell, accounted for 7% of all channels, consistent with
the number of cortical cells that are SOM (Tremblay et al.,
2016; SOM channel; Fig. 4A). After spike sorting, 72 SUs were
identified across all channels in superficial and deep layers, in-
cluding 63 broad (putative excitatory) units and 9 narrow (puta-
tive inhibitory) fast-spiking neurons. All units were effectively
silenced by SOM-cell activation, in line with the ability of
SOM cells to inhibit all other cortical cell types (Jiang et al.,
2015; Fig. 4B,C). Diffuse and persistent silencing was also ob-
tained with shorter (20 ms) laser pulses (data not shown). Thus,
multiunit OFF periods induced by SOM-cell activation appear
similar to those of physiological NREM sleep and, crucially, brief
optogenetic activation of SOM cells silences all recorded SUs
for a period that outlasts the stimulation—a characteristic feature
of the bistability of slow oscillations (Hill and Tononi, 2005).
OFF periods could also be triggered in wake and in REM sleep,
but they were significantly shorter than those triggered in NREM
sleep (wake: 154 20 ms, t(6)5.3, p 0.002 vs NREM sleep;
REM sleep: 143 20 ms, t(6)7.5, p 0.0003 vs NREM sleep;
paired t tests).
Chemogenetic activation of SOM cells increases NREM
sleep SWA, while their chemogenetic inhibition decreases it
Next, we tested whether selective chemogenetic activation of
SOM interneurons over a large portion of the cortex (bilateral
frontal and parietal) would promote a prolonged increase in
SWA. We chose a chemogenetic approach because it allows for
sustained depolarization of SOM cells without enforcing highly
synchronous activation as in optogenetic experiments. To con-
trol for the possible sedative effects of the selective ligand CNO
alone, CNO was injected in SOM mice expressing the excit-
atory receptor hM3Dq AAV, and in other mice expressing non-
hM3Dq AAV (controls). The effects of SOM-cell chemogenetic
activation on behavioral state and spectral activity in specific fre-
quency bands were assessed using LME models that included
mouse as a random effect, as well as day (baseline, CNO),
condition (group, e.g., hM3Dq, non-hM3Dq), and time (hour)
as categorical fixed effects. Specifically, we tested for a significant
condition*day interaction, since we hypothesized that there
would be differences between groups on the CNO day but not on
the baseline day. If a significant interaction was detected, post hoc
tests (adjusted for multiple comparisons) were used to confirm
whether a significant increase or decrease was only present during
the CNO day. With this approach, we could isolate the specific
effects of SOM-cell activation above and beyond the effects due
to CNO injection alone (controls). The same statistical approach
was used for SOM cell-inhibition and PV-cell activation ex-
periments (see below).
First, we confirmed that CNO administration in SOM-Cre
mice expressing hM3Dq drove activation of Fos, a marker of
neuronal activity, in SOM, hM3Dq neurons, indicating that
the drug was able to activate its target cells in vivo (Fig. 5A). Next,
SOM-Cre mice previously injected with either hM3Dq AAV or
non-hM3Dq AAV (n 6 mice/group) were administered CNO
(5 mg/kg) midway through the light phase, when most sleep pres-
sure has dissipated. After CNO injection, mice continued to cycle
through sleep–wake states and NREM sleep was characterized by
decreased muscle tone, slow waves in both frontal EEG and LFP
Table 3. LME, chemogenetic activation of PV cells log(SWA) during NREM
Estimate SE
Random effects
Mouse
Intercept 0.0260
Day–CNO (correlation with intercept: 0.52) 0.2041
Residual 0.0890
Fixed effects
Intercept 0.0021 0.0425
Condition (group)
Control (non-hM3Dq, reference) 0 0
hM3Dq 0.2031 0.0538
Day
Baseline (reference) 0 0
CNO 0.2081 0.1222
Hour
7 0 0
8 0.1963 0.0514
9 0.2074 0.0514
10 0.2121 0.0514
11 0.2130 0.0514
Condition*Day interaction
Control, baseline (reference) 0 0
hM3Dq, CNO 0.8224 0.1546
Condition*Hour interaction
7, control (reference) 0 0
8, hM3Dq 0.2417 0.0650
9, hM3Dq 0.2989 0.0650
10, hM3Dq 0.3131 0.0650
11, hM3Dq 0.3615 0.0650
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signals, and OFF periods in MUA (Fig. 5B,C), suggesting that,
qualitatively, physiological sleep continued following SOM-
cell activation. Quantitatively, relative to controls, SOM-cell
activation resulted in a sustained increase in NREM SWA in both
the frontal EEG (z 2.384, p 0.033, 19.8% increase), parietal
EEG (z  3.315, p  0.002, 15.1% increase), and M2 LFP (z 
4.371, p 2.4e-5, 49.74% increase) that lasted for the rest of the
light cycle (Fig. 5D). Further spectral analysis in M2 found a
broad shift toward lower-frequency activity during NREM sleep,
with a significant increase in SWA and  (6 – 8 Hz, z 6.59, p
8.7e-11, 40.6% increase), no significant change in 
 (8 –15 Hz,
z  1.772, p  0.133, 4.7% increase) and  (15–30 Hz, z 
1.734, p  0.157, 4.8% decrease), and a decrease in low-
(30 – 60 Hz, z5.167, p 4.7e-7, 12.4% decrease) and high-
(60 –100 Hz, z  6.011, p  3.7e-9, 12.6% decrease) bands
(Fig. 5E). There was no difference in spindle power between groups
(z 0.200, p 0.974, 0.5% increase) and a significant decrease in
spindle incidence (z3.755,p0.0003, 44.0% decrease). Similar
effects—increased SWA (z 3.657, p 0.0005, 60.2% increase), 
(z 2.629, p 0.0168, 35.8% increase), 
 (z 4.996, p 1.2e-6,
39.1% increase), and  (z  4.207, p  5.2e-5, 13.2% increase)
power and decreased low- (z  3.859, p  0.0002, 10.8% de-
crease) and high- (z5.401, p 1.3e-7, 15.7% decrease) pow-
er—were present in REM sleep (Fig. 5E). In wake, SWA increased
(z 3.576, p 0.0006, 54.2% increase) and high  decreased (z
3.957, p 0.000216.3% increase; Fig. 5E). Sleep architecture was
also modulated by SOM-cell activation, with a significant increase
in NREM sleep (z 2.722, p 0.0127, 21.8% increase) and a signif-
icant decrease in wake (z2.480,p0.0255, 34.9% decrease) and
REM sleep (z2.801, p 0.0097, 40.5% decrease; Fig. 5D).
To compare the effects of SOM-cell activation to well
known procedures that lead to increased sleep pressure and SWA,
we subjected the same SOM-Cre/AAV-hM3Dq animals to sleep
deprivation through exploration of novel objects for 6 h during
the first half of the light phase, a period during which mice are
normally asleep. For this analysis, we used an LME model that
compared baseline, sleep deprivation, and SOM activation in
the hM3Dq mice. Overall, the effects of sleep deprivation and
SOM-cell activation were similar, including increases in
NREM sleep (sleep deprivation: z  2.148, p  0.0782, 28.2%
increase; SOM: z 3.681, p 0.0007, 48.3% increase), frontal
EEG SWA (sleep deprivation: z  4.896, p  1.9e-6, 27.5% in-
Figure 2. Firing of SOM cells is locked to slow waves. A, Clustering results for one well isolated unit, in green, tagged by ChR2 stimulation (putative SOM). Yellow bars indicate the time of
laser stimulation (20ms).B, Raw LFP and activity from the same unit. C, Median firing rates (horizontal line) of the three tagged units calculated from 4 s epochs in the light period. Gray rectangles
denote 25th through 75th percentiles, with outliers plotted as blue circles. AW, Activewake; QW, quietwake.D, Median firing rates in recovery sleep (RS) after sleep deprivation (SD) comparedwith
early (E) and late (L) NREM sleep during baseline. FR, Firing rate; NR, baseline sleep. E, Correlation between unit firing and SWA in baseline sleep (NR) and recovery sleep after sleep deprivation (RS).
F, Firing is locked to local slowwaves and increases significantly (above red line) before their onset (0ms, definedby the zero crossingof each slowwave; seeMaterials andMethods; firingnormalized
for mean in NREM; red line is 99th percentile FR for simulated spike trains with shuffled ISIs).
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crease; SOM: z 2.690, p 0.0176, 19.2% increase), and pa-
rietal EEG SWA (sleep deprivation: z 2.227, p 0.0663, 14.6%
increase; SOM: z 2.362, p 0.0475, 13.8% increase). SOM
activation led to a greater increase in LFP SWA (sleep depriva-
tion: z  4.997, p  1.4e-6, 30.1% increase; SOM: z  7.786,
p  2.7e-14, 57.4% increase; SOM vs sleep deprivation: z 
3.463, p  0.0015, 21.0% increase), consistent with the stron-
gest effect being present in the area of virus expression. Con-
versely, sleep deprivation had no effect on the duration of
wake or REM sleep compared with baseline, while SOM
activation reduced time spent in wake (z  3.112, p 
0.0048, 14.0% decrease) and in REM sleep (z  5.238, p 
2.6e-7, 57.8% decrease; Fig. 6A,B). Thus, the enhancement of
slow frequencies after SOM-cell activation resembles that
induced by sleep deprivation.
The incidence and slope of the slow waves—two additional,
highly sensitive measures of sleep pressure (Vyazovskiy et al.,
2009b)—also increased in M2 after both sleep deprivation (slope:
z 3.425, p 0.0017, 7.6% increase; incidence: z 5.843, p
5.2e-9, 29.9% increase) and SOM-cell activation (slope: z5.828,
p1.5e-8, 16.8% increase; incidence: z6.137,p8.4e-10, 59.8%
increase; Fig. 6C–E). Moreover, analysis of laminar LFP record-
ings in baseline, recovery NREM sleep, and NREM sleep follow-
ing chemogenetic activation showed that in all cases slow waves
were largest in the LFP recordings from deep layers and were
accompanied by OFF periods across all layers (Fig. 6F), consis-
tent with previous reports from NREM sleep (Funk et al., 2016).
Thus, like sleep deprivation, chemogenetic activation of SOM
cells promotes the occurrence of slow waves that electrophysi-
ologically resemble those in natural NREM sleep and also in-
Figure 3. Firing of SOM cells during sleep spindles. A, Representative raw traces of SOM unit firing during spindles. B, Negative correlation between unit firing and spindle power
(10–16 Hz in NREM sleep).
Figure 4. Optogenetic activation of SOM cells triggers OFF periods during NREM sleep. A, Left, Example of MUA changes in two responding (SOM, green) channels and several SOM
channels after laser stimulation (yellow bar, 50ms). Right, MeanMUA changes for all SOM and SOM channels (7mice). Inset, Expanded y-axis to show the firing of SOM channels after laser
pulse. B, Left, Change in firing in one broad unit (putative excitatory, spike waveform shown on top). Right, Mean of all broad units. C, As in B for narrow (putative inhibitory) units.
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creases their slope, a sign of enhanced neuronal synchrony
(Vyazovskiy et al., 2009b). Altogether, these results suggest that
the stimulation of SOM cells may promote the same physiolog-
ical mechanisms underlying sleep slow waves.
Other SOM-Cre mice were injected with the inhibitory recep-
tor hM4Di (M4, n  5 mice) or non-hM4Di AAV (M4,
controls, n  5 mice). After CNO, hM4Di mice spent sig-
nificantly more time in REM sleep than controls (z  3.422,
Figure 5. Chemogenetic SOM-cell activation leads to a sustained increase in SWA.A, Fos induction in SOM, hM3Dq neurons after CNO.B, Effects on sleep and SWA (NREMM2 LFP power,
0.5– 4.5 Hz, M2) in one representative SOM-Cre hM3Dqmouse given CNO (5 mg/kg, i.p.) in the middle of the light phase. Hypnograms and spectra shown for entire light period (12 h). C, Raw
traces from the same animal on baseline and post-CNO. D, Sleep/wake and SWA percentages in baseline (B) and after CNO in mice expressing hM3Dq AAV (M3, 6 mice) and mice expressing
non-hM3Dq AAV (controls, M3, 6 mice). For each parameter, the left panel shows the hour-by-hour data, which were used to run the LMEmodels, locked to first sleep bout after the start of the
light period and aftermidpoint of the light period (when CNOwas given); if a significant condition (group)*day interactionwas found,post hoc testswere run to isolate themain effect of CNO (right).
*p	 0.05; **p	 0.01; ***p	 0.001. E, Power spectra for the second half of the light period in each vigilance state.
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Figure 6. Chemogenetic SOM activation leads to changes in SWAand individual slowwaves similar to those seen after sleep deprivation.A, Percentage time spent in sleep/wake, EEG, andM2
LFP SWA for baseline (B), recovery sleep after sleep deprivation (SD), and CNO experiments. For each sleep parameter hour-by-hour data locked to first sleep bout after the start of the light period
and after 2:00 P.M. are shown; hour-by-hour data were used for the LME models, and if a significant condition*day interaction was found, post hoc tests were (Figure legend continues.)
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p 0.0012, 56.6% increase), but did not differ from controls in
the time spent awake or in NREM sleep. By contrast they showed,
during NREM sleep, a persistent decrease in SWA (z4.612,
p  7.9e-6, 18.6% decrease; Fig. 7A–D), associated with a de-
crease in the incidence of slow waves (z  4.077, p  8.9e-5,
23.3% decrease) as well as a decrease in SWA during REM sleep
(z4.458, p 1.7e-5, 20.1% decrease).
Characterization of SOM c-fos expression in natural sleep
Previous work has described a group of cortical neurons contain-
ing high levels of nNOS—type-I nNOS cells—that expresses
Fos during early recovery sleep, when SWA is high (Gerash-
chenko et al., 2008). We first confirmed this finding in two mice,
4
(Figure legend continued.) run to isolate themain effect of CNO (right).B, Power spectra for the
second half of light period in each vigilance state. Spectra are shown for hours (Hrs) 7–12, to
compare directly sleep deprivation and CNO experiments, and for the first hour after sleep
deprivation (Hr 7), when the effects aremost prominent. C, Raw LFP andMUA fromNREM sleep
for B, SD, and CNO experiments.D, Schematic of how individual slowwaveswere automatically
identified. E, Slow-wave (SW) incidence (top) and slope (bottom), plotted as inA. F, Left, Depth
profile of individual slowwaves from baseline NREM sleep (top) andmeanMUA locked to slow
waves (bottom; blue corresponds to the OFF periods). Slow-wave onset is at 0ms (zero crossing
of each slow wave; see Materials and Methods). Middle, Right, Same for recovery sleep
after SD (first hour) and sleep after CNO (last 5 h of the light period). *p 	 0.05;
**p	 0.01; ***p	 0.001.
Figure 7. Chemogenetic inactivation of SOM cells leads to a sustained decrease in SWA. A, B, Effects on sleep and SWA in M2 during the light period in one representative SOM-Cre hM4Di
mouse given CNO (10mg/kg, i.p.) at light onset, and raw traces from the same animal in the second hour after injection. C, Effects on behavioral states and SWA after CNO (M4, 5 mice; controls,
M45mice). For eachparameter, the left panel showshour-by-hour data locked to the first sleepbout after the start of the light period (whenCNOwasgiven),while the right panel shows themean
values from the first half of the light period. LMEmodelswere runonhour-by-hour data; if a significant condition (group)*day interactionwas found,post hoc testswere run to isolate themain effect
of CNO (right). **p	 0.01; ***p	 0.001. D, Power spectra for the first half of the light period in each vigilance state.
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in which we found that after 90 min of recovery sleep following
6 h of sleep deprivation most nNOS cells were also Fos
(61%), and were mainly located in deep layers, as previously
reported (Kilduff et al., 2011; data not shown). Since all type-I
nNOS cells are also SOM cells but not vice versa (Kilduff et
al., 2011), we assessed in other mice (n  6) Fos expression in
SOM cells and found that only a small subset of SOM neu-
rons were Fos during recovery sleep. Conversely, many Fos
cells during recovery sleep were not SOM cells, and Fos cells
were found in all cortical layers (Fig. 8). It should be noted that
the mean firing rates of most cortical cells are only slightly de-
creased throughout sleep relative to wake and the relationship
between spontaneous neuronal activity and Fos expression is not
straightforward (Kawashima et al., 2014).
Activation of PV cells decreases SWA in NREM sleep
Is the induction of physiological slow waves and NREM sleep
specific to SOM neurons? The most numerous population of
cortical inhibitory cells are PV (Tremblay et al., 2016). Using a
PV-Cre line, we first confirmed that unlike SOM cells, PV
neurons have local projections and their axons mostly avoid L1
(Jiang et al., 2015; Fig. 9A). Optogenetic stimulation of PV cells
produced a more transient silencing in response to laser pulses
than did optogenetic activation of SOM cells (Fig. 9B; latency to
first post-pulse spike, mean  SD: SOM, 128  48 ms; PV,
59 19 ms, t(10) 3, p 0.01, unpaired t test; 7 SOMmice and
5 PVmice). Next, we confirmed that CNO induces Fos expres-
sion in PV, hM3Dq neurons (Fig. 9C), as it does in SOM,
hM3Dq cells. Relative to controls injected with non-hM3Dq
AAV, chemogenetic activation of PV cells led to a marked de-
crease in M2 SWA during NREM sleep (z4.817, p 2.9e-6,
54.3% decrease; Fig. 9D–F; n  5 mice), as well as in all other
major frequency bands (: z  2.054, p  0.0784, 23.5% de-
crease;
: z2.523, p 0.0231, 27.5% decrease;: z3.057,
p 0.0045, 31.9% decrease; low: z4.603, p 8.4e-6, 49.4%
decrease; high : z  4.308, p  3.3e-5, 56.0% decrease; Fig.
9G). PV-cell activation also increased the duration of behavior-
ally and polygraphically defined NREM sleep (z  3.070, p 
0.0043, 17.6% increase) and decreased the duration of REM sleep
(z  2.362, p  0.036, 35.8% decrease; Fig. 9F). Consistent
with this broad power decline, during chemogenetic activation of
PV cells cortical firing was profoundly suppressed during
NREM sleep (hours 7–12 post-CNO vs hours 1– 6 pre-CNO),
much more than after activation of SOM cells (z5.262, p
1.4e-7, 53.6% decrease). In contrast, PV-cell activation led to a
broad increase in LFP power during REM sleep (SWA: z 9.476,
p 	 2e-16, 160% increase; : z  6.608, p  7.8e-11, 256% in-
crease, 
: z 6.153, p 1.5e-9, 112% increase; : z 3.841, p
0.0002, 61.6% increase; Fig. 9G) and during wake (SWA: z 
3.27, p 0.0021, 42.9% increase; : z 3.651, p 0.0005, 56.3%
increase; 
: z 2.389, p 0.0335, 50.9% increase; Fig. 9G).
Discussion
These findings show that slow waves—the hallmark of NREM
sleep—are positively regulated by a population of SOM cortical
inhibitory interneurons. SOM cells fire just before the occur-
rence of slow waves and their acute optogenetic activation pro-
duces a sustained neuronal OFF period across putative excitatory
and inhibitory neurons, consistent with the broad connectivity of
SOM cells. Sustained chemogenetic activation of SOM cells
enhances SWA and the slope of individual slow waves, while their
chemogenetic inhibition decreases SWA and slow-wave inci-
dence. In contrast, PV-cell activation profoundly suppresses
SWA and cortical activity in general, demonstrating that the pos-
itive role SOM cells in the generation of sleep slow waves is not
shared by all GABAergic cortical interneurons.
A hallmark of NREM SWA is its homeostatic regulation (Bor-
be´ly and Achermann, 2005; Borbe´ly et al., 2016). Chemogenetic
activation of SOM cells produced an increase in SWA, slow-
wave slope, and incidence that resembled the changes seen with
sleep deprivation in the same animals. Moreover, SOM firing
levels correlated with SWA in recovery sleep, consistent with a
possible link between SOM activity and increased SWA in nat-
ural recovery sleep. Thus, not only is the cortical SOM-cell
network, with its dense local L1 projections, long-distance corti-
cal projections (Wang et al., 2004), and gap junctions (Ma et al.,
Figure 8. SOM-cell Fos expression in natural sleep. A, Left, Experimental design for Fos experiments: mice were sleep deprived by exposure to novel objects for 6 h and then either killed
immediately (SD, n 2) or allowed to recover sleep for 90min (RS, n 4). Right, Schematic of the six coronal sections used in eachmouse, with the red rectangles showing the cortical areas used
for cell counting. B, Representative examples of the expression of SOM, Fos, and their colocalization in the frontal cortex of one SD and one RS mouse. C, Mean number of double-labeled cells
(SOMFos) expressed as percentage relative to all SOM cells (gray) or relative to all Fos cells (black) across all layers. Average cell counts across all cortical areas in SD: SOM, 1060 74;
Fos, 197077; SOMFos, 192. Cell counts inRS: SOM, 1014259; Fos, 274131; SOMFos, 277.D,E, As inC, for superficial layers (1–3) anddeep layers (4– 6) separately.
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Figure 9. PV activation decreases SWA in NREM sleep. A, Cortical projections shown in sagittal and coronal sections from a representative PV-Cre mouse injected with
AAV1.CAG.Flex.eGFP.WPRE.bGH, with sparse innervation in L1. B, Optogenetic stimulation of PV cells leads to transient suppression of MUA (5mice). C, Fos induction after CNO.D, E, Increase in
NREMsleeppercentagebutdecrease inM2SWAfollowingCNO inone representativemousegivenCNO (5mg/kg, i.p.) in themiddleof theday, and rawtraces fromthe sameanimal during the second
hour after injection. F, Effects on behavioral states and SWA (M3, 5 mice; controls, M3, 3 mice). For each parameter, the left panel shows hour-by-hour data, which were used to run the LME
models, locked to the first sleep bout after the start of the light period and aftermidpoint of the light period (when CNOwas given); if a significant condition (group)*day interactionwas found, post
hoc tests were run to isolate the main effect of CNO (right). *p	 0.05; **p	 0.01; ***p	 0.001. G, Power spectra for the second half of the light period in each vigilance state.
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2006; Fanselow et al., 2008) effectively able to induce SWA, but
the overall level of activity in this network may also contribute to
the homeostatic regulation of SWA.
Slow waves can change globally or locally in response to wake-
induced changes in cortical activity and plasticity, often without
any effect on NREM sleep duration (Borbe´ly and Achermann,
2005; Davis et al., 2011; Krueger and Tononi, 2011; Borbe´ly et al.,
2016). Whether local variations in SOM activity lead to local
up-regulation in SWA remains unknown. Previous research
shows that at the population level, firing rate of cortical excit-
atory neurons in NREM sleep is elevated when sleep pressure is
increased (Vyazovskiy et al., 2009b). Given that excitatory syn-
apses on SOM cells are facilitating (Silberberg and Markram,
2007; Fanselow and Connors, 2010), the increased firing of excit-
atory cells could in turn drive increases in SOM activity. Thus,
we speculate that SOM cells could be effectively poised to trans-
duce increased excitatory-cell firing into increased SWA, and,
given their extensive axonal projections, could do so at the global
level, as well as locally.
Although the chemogenetic activation of SOM cells and
PV cells had opposite effects on SWA, it led in both cases to an
increase in time spent in NREM sleep. SOM inactivation in-
stead decreased SWA but had no effect on NREM sleep duration.
Altogether, these results suggest that at least partially different
mechanisms regulate SWA and NREM sleep amount, in line with
previous studies showing that changes in the “intensity” of NREM
sleep, as reflected by SWA, can be dissociated from changes in its
duration (Borbe´ly and Achermann, 2005; Davis et al., 2011;
Krueger and Tononi, 2011). For instance, several drugs and dif-
ferent regimes of sleep deprivation can affect either NREM sleep
or slow waves, or change both but in opposite directions (Borbe´ly
and Achermann, 2005; Davis et al., 2011). Here, we employed
large-volume virus injections in bilateral frontal and parietal re-
gions. It is possible that increasing GABAergic tone in multiple
cortical areas promoted the increase in NREM sleep, though this
remains highly speculative. The effect of SOM-cell and PV-
cell activation may have further been augmented by spread of
activation through gap junctions (Ma et al., 2006; Fanselow et al.,
2008), which could be tested in the future by combining chemo-
genetic activation with pharmacological manipulation of gap junc-
tions. Finally, SOM cells have long-distance cortical (Wang et
al., 2004) and subcortical (Melzer et al., 2017) projections, which
could contribute to the regulation of behavioral states. A recent
study characterized two types of corticostriatal neurons, SOM
cells and PV cells, and found that they differentially regulate
locomotion (Melzer et al., 2017). The same study also identified
occasional projections from corticostriatal SOM cells to basal
forebrain and thalamic nuclei involved in arousal circuitry (Mel-
zer et al., 2017), and future studies focusing on these projections
may lead to identification of “top-down” circuits for regulation
of behavioral state.
We found that activation of PV cells led to decreased SWA,
indicating that not all interneuron subtypes induce slow waves.
Nonetheless, it is possible that in addition to SOM cells, other
inhibitory cell types play a role in the generation of slow waves.
Indeed, analysis of neuronal Fos expression in recovery sleep
revealed numerous Fos SOM cells. We do not know whether
these cells belong to a specific subtype, or are a heterogeneous
population. One candidate group are neurogliaform cells. These
cells can induce indiscriminate GABAB-mediated hyperpolariza-
tion through volume transmission (Ola´h et al., 2009; Tremblay et
al., 2016), although their effects on synaptic strength are less pow-
erful than those of SOM cells (Urban-Ciecko et al., 2015).
Moreover, neurogliaform cells are prominent in L1, where we
observed only sparse Fos cells during recovery sleep. Other in-
terneuron subtypes may negatively regulate slow waves through
their effects on the activity and excitability of SOM cells. SOM
cells are inhibited by cortical vasoactive intestinal polypeptide in-
terneurons (Pfeffer et al., 2013) that fire during locomotion and
are themselves under the control of arousal systems (Stryker,
2014) and by PV interneurons in the basal forebrain, which are
wake-on and promote wake (Xu et al., 2015). Finally, the activity
of other interneuron subtypes in NREM sleep may have functions
unrelated to SWA per se. For instance, PV activation increased
NREM sleep, suggesting a possible role for these cells in NREM
sleep independent of SWA. Future research on state-specific ac-
tivity of cortical interneuron subtypes is likely to reveal rich het-
erogeneity in the contribution of these cell types to sleep rhythms
and function.
Another open question is whether SOM cells in other parts
of the brain regulate behavioral or electrophysiological properties
of NREM sleep. In the CA1 region of the hippocampus, bistrati-
fied SOM cells exhibit increased firing during sharp-wave rip-
ples, while oriens lacunosum-moleculare SOM cells exhibit
little modulation or, in some cases, decreased firing (Katona et
al., 2014). In contrast with the differential regulation of SWA by
cortical SOM and PV cells, optogenetic activation of PV
and SOM cells in CA1 produced similar disruption of sharp-
wave ripples (Stark et al., 2014). In the basal forebrain, SOM
cells inhibit all types of neighboring wake-promoting neurons
and their optogenetic activation slightly increases NREM sleep,
consistent with the finding that a minority of these cells is more
active during NREM sleep (Xu et al., 2015). Also, subcortical
wake-promoting and sleep-promoting systems also directly reg-
ulate SOM activity. For instance, noradrenaline, a neuromodu-
lator released at high levels in wake and at low levels in sleep,
reduces the effectiveness of synapses between SOM and pyra-
midal cells (Koyanagi et al., 2010) and the conductivity of gap
junctions (Zsiros and Maccaferri, 2008), possibly preventing the
induction and synchronization of sleep slow waves.
We used a SOM-Cre line that broadly labels both Martinotti
and non-Martinotti SOM cells. The widespread L1 projections
of Martinotti cells, which comprise70% of SOM cells, makes
them the primary candidate for mediating the induction of sleep
slow waves reported here, but definitive evidence will require
repeating these experiments in Martinotti-specific Cre lines. To
our knowledge, no Martinotti-specific Cre line is currently avail-
able, although a recent study demonstrated that the Chrna2-Cre
line labels Martinotti interneurons in layer 5 of the cortex (Hilscher et
al., 2017). However, only a small percentage of layer-2/3 Marti-
notti cells were labeled by this line, meaning that the SOM-Cre
line remains the best tool for labeling all Martinotti cells across
layers. Future experiments should establish the contribution of
other cortical subpopulations of SOM cells (McGarry et al.,
2010), such as non-Martinotti cells in layer 4 (Xu et al., 2013) and
nNOS cells (Kilduff et al., 2011). The latter are of particular in-
terest, as nNOS cells exhibit increased Fos expression after recov-
ery sleep (Kilduff et al., 2011) and NREM SWA is decreased in
nNOS knock-out mice (Morairty et al., 2013). Another limitation
of this study was the use of laminar probes implanted in a fixed
position, which led to a small yield of well-isolated optogeneti-
cally tagged SOM units. Finally, the unit data were recorded in
M2, raising the question of whether SOM cells in other cortical
areas exhibit similar properties.
9146 • J. Neurosci., September 20, 2017 • 37(38):9132–9148 Funk et al. • SOM Cells and Sleep SlowWaves
References
Bates D, Maechler M, Bolker B, Walker S (2015) Fitting linear mixed-effects
models using lme4. J Stat Software 67:1– 48. CrossRef
Borbe´ly AA, Achermann P (2005) Sleep homeostasis and models of sleep
regulation. In: Principles and practice of sleep medicine (Kryer MH, Roth
T, Dement WC, eds.), pp 405– 417. Philadelphia: Elsevier Saunders.
Borbe´ly AA, Daan S, Wirz-Justice A, Deboer T (2016) The two-process
model of sleep regulation: a reappraisal. J Sleep Res 25:131–143. CrossRef
Medline
Bretz F, Hothorn T, Westfall P (2011) Multiple comparisons using R. Boca
Raton, FL: CRC.
Cauller L (1995) Layer I of primary sensory neocortex: where top-down
converges upon bottom-up. Behav Brain Res 71:163–170. CrossRef
Medline
Chiu CQ, Lur G, Morse TM, Carnevale NT, Ellis-Davies GC, Higley MJ
(2013) Compartmentalization of GABAergic inhibition by dendritic
spines. Science 340:759 –762. CrossRef Medline
Craig MT, McBain CJ (2014) The emerging role of GABAB receptors as
regulators of network dynamics: fast actions from a ‘slow’ receptor? Curr
Opin Neurobiol 26:15–21. CrossRef Medline
Craig MT, Mayne EW, Bettler B, Paulsen O, McBain CJ (2013) Distinct
roles of GABAB1a- and GABAB1b-containing GABAB receptors in spon-
taneous and evoked termination of persistent cortical activity. J Physiol
591:835– 843. CrossRef Medline
Crunelli V, David F, Lo˝rinczML, Hughes SW (2015) The thalamocortical
network as a single slow wave-generating unit. Curr Opin Neurobiol
31:72– 80. CrossRef Medline
Davis CJ, Clinton JM, Jewett KA, Zielinski MR, Krueger JM (2011) Delta
wave power: an independent sleep phenotype or epiphenomenon? J Clin
Sleep Med 7:S16 –S18. CrossRef Medline
Fanselow EE, Connors BW (2010) The roles of somatostatin-expressing
(GIN) and fast-spiking inhibitory interneurons in UP-DOWN states of
mouse neocortex. J Neurophysiol 104:596 – 606. CrossRef Medline
Fanselow EE, Richardson KA, Connors BW (2008) Selective, state-depen-
dent activation of somatostatin-expressing inhibitory interneurons in
mouse neocortex. J Neurophysiol 100:2640 –2652. CrossRef Medline
Fino E, Yuste R (2011) Dense inhibitory connectivity in neocortex. Neuron
69:1188 –1203. CrossRef Medline
Funk CM, Honjoh S, Rodriguez AV, Cirelli C, Tononi G (2016) Local slow
waves in superficial layers of primary cortical areas during REM sleep.
Curr Biol 26:396 – 403. CrossRef Medline
Gentet LJ, Kremer Y, Taniguchi H, Huang ZJ, Staiger JF, Petersen CC (2012)
Unique functional properties of somatostatin-expressing GABAergic
neurons in mouse barrel cortex. Nat Neurosci 15:607– 612. CrossRef
Medline
Gerashchenko D, Wisor JP, Burns D, Reh RK, Shiromani PJ, Sakurai T, de la
Iglesia HO, Kilduff TS (2008) Identification of a population of sleep-
active cerebral cortex neurons. Proc Natl Acad Sci U S A 105:10227–
10232. CrossRef Medline
Hamm JP, Yuste R (2016) Somatostatin interneurons control a key compo-
nent of mismatch negativity in mouse visual cortex. Cell Rep 16:597– 604.
CrossRef Medline
Harris JA, Oh SW, Zeng H (2012) Adeno-associated viral vectors for antero-
grade axonal tracing with fluorescent proteins in nontransgenic and cre
driver mice. Curr Protoc Neurosci Chapter 1: Unit 1.20.1–18. CrossRef
Medline
Hill DN, Mehta SB, Kleinfeld D (2011) Quality metrics to accompany
spike sorting of extracellular signals. J Neurosci 31:8699–8705. CrossRef
Medline
Hill S, Tononi G (2005) Modeling sleep and wakefulness in the thalamocor-
tical system. J Neurophysiol 93:1671–1698. CrossRef Medline
Jiang X, Shen S, Cadwell CR, Berens P, Sinz F, Ecker AS, Patel S, Tolias AS
(2015) Principles of connectivity among morphologically defined cell
types in adult neocortex. Science 350:aac9462. CrossRef Medline
Kapfer C, Glickfeld LL, Atallah BV, Scanziani M (2007) Supralinear increase
of recurrent inhibition during sparse activity in the somatosensory cortex.
Nat Neurosci 10:743–753. CrossRef Medline
Katona L, Lapray D, Viney TJ, Oulhaj A, Borhegyi Z, Micklem BR, Klaus-
berger T, Somogyi P (2014) Sleep and movement differentiates actions
of two types of somatostatin-expressing GABAergic interneuron in rat
hippocampus. Neuron 82:872– 886. CrossRef Medline
Kawashima T, Okuno H, Bito H (2014) A new era for functional labeling of
neurons: activity-dependent promoters have come of age. Front Neural
Circuits 8:37. CrossRef Medline
Kilduff TS, Cauli B, Gerashchenko D (2011) Activation of cortical interneu-
rons during sleep: an anatomical link to homeostatic sleep regulation?
Trends Neurosci 34:10 –19. CrossRef Medline
Koyanagi Y, Yamamoto K, Oi Y, Koshikawa N, Kobayashi M (2010) Presyn-
aptic interneuron subtype- and age-dependent modulation of GABAergic
synaptic transmission by beta-adrenoceptors in rat insular cortex. J Neu-
rophysiol 103:2876 –2888. CrossRef Medline
Krishnamurthy P, Silberberg G, Lansner A (2012) A cortical attractor net-
work with Martinotti cells driven by facilitating synapses. PloS One
7:e30752. CrossRef Medline
Krueger JM, Tononi G (2011) Local use-dependent sleep; synthesis of the
new paradigm. Curr Top Med Chem 11:2490 –2492. CrossRef Medline
Kubota Y, Hattori R, Yui Y (1994) Three distinct subpopulations of GABAe-
rgic neurons in rat frontal agranular cortex. Brain Res 649:159 –173.
CrossRef Medline
Laird NM, Ware JH (1982) Random effects models for longitudinal data.
Biometrics 38:963–974. CrossRef Medline
Lee CK, Huguenard JR (2011) Martinotti cells: community organizers.
Neuron 69:1042–1045. CrossRef Medline
Lemieux M, Chauvette S, Timofeev I (2015) Neocortical inhibitory activi-
ties and long-range afferents contribute to the synchronous onset of silent
states of the neocortical slow oscillation. J Neurophysiol 113:768 –779.
CrossRef Medline
Li H, Penzo MA, Taniguchi H, Kopec CD, Huang ZJ, Li B (2013)
Experience-dependent modification of a central amygdala fear circuit.
Nat Neurosci 16:332–339. CrossRef Medline
Ma Y, Hu H, Berrebi AS, Mathers PH, Agmon A (2006) Distinct subtypes of
somatostatin-containing neocortical interneurons revealed in transgenic
mice. J Neurosci 26:5069 –5082. CrossRef Medline
Markov NT, Vezoli J, Chameau P, Falchier A, Quilodran R, Huissoud C,
Lamy C, Misery P, Giroud P, Ullman S, Barone P, Dehay C, Knoblauch K,
Kennedy H (2014) Anatomy of hierarchy: feedforward and feedback
pathways in macaque visual cortex. J Comp Neurol 522:225–259. CrossRef
Medline
Massimini M, Huber R, Ferrarelli F, Hill S, Tononi G (2004) The sleep
slow oscillation as a traveling wave. J Neurosci 24:6862– 6870. CrossRef
Medline
Massimini M, Ferrarelli F, Esser SK, Riedner BA, Huber R, Murphy M, Peter-
son MJ, Tononi G (2007) Triggering sleep slow waves by transcranial
magnetic stimulation. Proc Natl Acad Sci U S A 104:8496–8501. CrossRef
Medline
McGarry LM, Packer AM, Fino E, Nikolenko V, Sippy T, Yuste R (2010)
Quantitative classification of somatostatin-positive neocortical interneu-
rons identifies three interneuron subtypes. Front Neural Circuits 4:12.
CrossRef Medline
Melzer S, Gil M, Koser DE, Michael M, Huang KW, Monyer H (2017) Dis-
tinct corticostriatal GABAergic neurons modulate striatal output neurons
and motor activity. Cell Rep 19:1045–1055. CrossRef Medline
Morairty SR, Dittrich L, Pasumarthi RK, Valladao D, Heiss JE, Gerashchenko
D, Kilduff TS (2013) A role for cortical nNOS/NK1 neurons in coupling
homeostatic sleep drive to EEG slow wave activity. Proc Natl Acad Sci
U S A 110:20272–20277. CrossRef Medline
Neske GT, Patrick SL, Connors BW (2015) Contributions of diverse excit-
atory and inhibitory neurons to recurrent network activity in cerebral
cortex. J Neurosci 35:1089 –1105. CrossRef Medline
Nir Y, Staba RJ, Andrillon T, Vyazovskiy VV, Cirelli C, Fried I, Tononi G
(2011) Regional slow waves and spindles in human sleep. Neuron 70:
153–169. CrossRef Medline
Ola´h S, Fu¨le M, Komlo´si G, Varga C, Ba´ldi R, Barzo´ P, Tama´s G (2009)
Regulation of cortical microcircuits by unitary GABA-mediated volume
transmission. Nature 461:1278 –1281. CrossRef Medline
Oostenveld R, Fries P, Maris E, Schoffelen JM (2011) FieldTrip: open source
software for advanced analysis of MEG, EEG, and invasive electrophysi-
ological data. Comput Intell Neurosci 2011:156869. CrossRef Medline
Pfeffer CK, Xue M, He M, Huang ZJ, Scanziani M (2013) Inhibition of
inhibition in visual cortex: the logic of connections between molecularly
distinct interneurons. Nat Neurosci 16:1068 –1076. CrossRef Medline
Pinto L, Dan Y (2015) Cell-type-specific activity in prefrontal cortex during
goal-directed behavior. Neuron 87:437– 450. CrossRef Medline
Quiroga RQ, Nadasdy Z, Ben-Shaul Y (2004) Unsupervised spike detection
Funk et al. • SOM Cells and Sleep SlowWaves J. Neurosci., September 20, 2017 • 37(38):9132–9148 • 9147
and sorting with wavelets and superparamagnetic clustering. Neural
Comput 16:1661–1687. CrossRef Medline
Silberberg G, Markram H (2007) Disynaptic inhibition between neocortical
pyramidal cells mediated by Martinotti cells. Neuron 53:735–746.
CrossRef Medline
Stark E, Roux L, Eichler R, Senzai Y, Royer S, Buzsa´ki G (2014) Pyramidal
cell-interneuron interactions underlie hippocampal ripple oscillations.
Neuron 83:467– 480. CrossRef Medline
Steriade M (2000) Corticothalamic resonance, states of vigilance and men-
tation. Neuroscience 101:243–276. CrossRef Medline
Stryker MP (2014) A neural circuit that controls cortical state, plasticity,
and the gain of sensory responses in mouse. Cold Spring Harb Symp
Quant Biol 79:1–9. CrossRef Medline
Taniguchi H, He M, Wu P, Kim S, Paik R, Sugino K, Kvitsani D, Fu Y, Lu J, Lin
Y, Miyoshi G, Shima Y, Fishell G, Nelson SB, Huang ZJ (2011) A re-
source of Cre driver lines for genetic targeting of GABAergic neurons in
cerebral cortex. Neuron 71:995–1013. CrossRef Medline
Tremblay R, Lee S, Rudy B (2016) GABAergic Interneurons in the neocor-
tex: from cellular properties to circuits. Neuron 91:260 –292. CrossRef
Medline
Urban DJ, Roth BL (2015) DREADDs (designer receptors exclusively acti-
vated by designer drugs): chemogenetic tools with therapeutic utility.
Annu Rev Pharmacol Toxicol 55:399 – 417. CrossRef Medline
Urban-Ciecko J, Barth AL (2016) Somatostatin-expressing neurons in cor-
tical networks. Nat Rev Neurosci 17:401– 409. CrossRef Medline
Urban-Ciecko J, Fanselow EE, Barth AL (2015) Neocortical somatostatin
neurons reversibly silence excitatory transmission via GABAb receptors.
Curr Biol 25:722–731. CrossRef Medline
Volgushev M, Chauvette S, Mukovski M, Timofeev I (2006) Precise long-
range synchronization of activity and silence in neocortical neurons
during slow-wave oscillations [corrected]. J Neurosci 26:5665–5672.
CrossRef Medline
Vyazovskiy VV, Riedner BA, Cirelli C, Tononi G (2007) Sleep homeostasis
and cortical synchronization: II. A local field potential study of sleep slow
waves in the rat. Sleep 30:1631–1642. CrossRef Medline
Vyazovskiy VV, Faraguna U, Cirelli C, Tononi G (2009a) Triggering slow
waves during NREM sleep in the rat by intracortical electrical stimulation:
effects of sleep/wake history and background activity. J Neurophysiol
101:1921–1931. CrossRef Medline
Vyazovskiy VV, Olcese U, Lazimy YM, Faraguna U, Esser SK, Williams JC,
Cirelli C, Tononi G (2009b) Cortical firing and sleep homeostasis. Neu-
ron 63:865– 878. CrossRef Medline
Wang Y, Toledo-Rodriguez M, Gupta A, Wu C, Silberberg G, Luo J, Markram
H (2004) Anatomical, physiological and molecular properties of Marti-
notti cells in the somatosensory cortex of the juvenile rat. J Physiol 561:
65–90. CrossRef Medline
Wang Y, Neubauer FB, Lu¨scher HR, Thurley K (2010) GABAB receptor-
dependent modulation of network activity in the rat prefrontal cortex in
vitro. Eur J Neurosci 31:1582–1594. CrossRef Medline
Wess J, Nakajima K, Jain S (2013) Novel designer receptors to probe GPCR
signaling and physiology. Trends Pharmacol Sci 34:385–392. CrossRef
Medline
Xu H, Jeong HY, Tremblay R, Rudy B (2013) Neocortical somatostatin-
expressing GABAergic interneurons disinhibit the thalamorecipient
layer 4. Neuron 77:155–167. CrossRef Medline
Xu M, Chung S, Zhang S, Zhong P, Ma C, Chang WC, Weissbourd B, Sakai N,
Luo L, Nishino S, Dan Y (2015) Basal forebrain circuit for sleep–wake
control. Nat neuroscience 18:1641–1647. CrossRef Medline
Zsiros V, Maccaferri G (2008) Noradrenergic modulation of electrical cou-
pling in GABAergic networks of the hippocampus. J Neurosci 28:1804 –
1815. CrossRef Medline
9148 • J. Neurosci., September 20, 2017 • 37(38):9132–9148 Funk et al. • SOM Cells and Sleep SlowWaves
